Literature DB >> 7495217

Congestive heart failure due to hypertensive ventricular diastolic dysfunction.

M M Iriarte1, J Perez Olea, D Sagastagoitia, E Molinero, N Murga.   

Abstract

Left ventricular (LV) diastolic dysfunction is the first discernible manifestation of heart disease in hypertensive patients. Arterial hypertension with LV hypertrophy leads to reduced preload followed by impaired cardiac output (systolic dysfunction stemming from primary diastolic dysfunction). Diastolic dysfunction leads more often than systolic dysfunction to hypertensive heart failure and is in many cases clearly distinguishable from heart failure with low ejection fraction (EF). Mortality due to heart failure from impaired inotropism is higher than mortality due to diastolic dysfunction, but morbidity is lower. Hypertensive cardiomyopathies can be divided into 4 ascending categories, according to the pathophysiologic and clinical impact of hypertension on the heart: Degree I: LV diastolic dysfunction with no associated LV hypertrophy Degree II: LV diastolic dysfunction with echocardiographic LV hypertrophy Degree IIA: Normal exercise capacity in terms of maximal oxygen consumption Degree IIB: Impaired exercise capacity in terms of maximal oxygen consumption Degree III: Congestive heart failure (severe dyspnea and radiographically determined pulmonary edema with normal (> or = 50%) EF Degree IIIA: LV mass/volume ratio > 1.8 with little or no myocardial ischemia Degree IIIB: LV mass/volume ratio < 1.8 with significant myocardial ischemia Degree IV: Profile of dilated cardiomyopathy; LV hypertrophy and impaired EF (< 50%).

Entities:  

Mesh:

Year:  1995        PMID: 7495217     DOI: 10.1016/s0002-9149(99)80491-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Exercise intolerance.

Authors:  Dalane W Kitzman; Leanne Groban
Journal:  Heart Fail Clin       Date:  2008-01       Impact factor: 3.179

2.  Postrenal biopsy AVM leading to severe hypertension and dilated cardiomyopathy.

Authors:  Nao Sasaki; Umesh C Joashi; Marcela Vergara; Jeffrey M Saland; Barry A Love
Journal:  Pediatr Nephrol       Date:  2009-08-04       Impact factor: 3.714

3.  Exercise intolerance.

Authors:  Dalane W Kitzman; Leanne Groban
Journal:  Cardiol Clin       Date:  2011-08       Impact factor: 2.213

4.  Coexistence of obstructive sleep apnoea and metabolic syndrome is independently associated with left ventricular hypertrophy and diastolic dysfunction.

Authors:  Yasuhiro Usui; Yoshifumi Takata; Yuichi Inoue; Katsunori Shimada; Hirofumi Tomiyama; Yosuke Nishihata; Kota Kato; Kazuki Shiina; Akira Yamashina
Journal:  Sleep Breath       Date:  2011-07-21       Impact factor: 2.816

5.  The prevalence of diastolic dysfunction in adult hypertensive nigerians.

Authors:  So Ike; Vo Ikeh
Journal:  Ghana Med J       Date:  2006-06

6.  Relationships between body fat distribution, epicardial fat and obstructive sleep apnea in obese patients with and without metabolic syndrome.

Authors:  Carla Lubrano; Maurizio Saponara; Giuseppe Barbaro; Palma Specchia; Eliana Addessi; Daniela Costantini; Marta Tenuta; Gabriella Di Lorenzo; Giuseppe Genovesi; Lorenzo M Donini; Andrea Lenzi; Lucio Gnessi
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

7.  Carotid atherosclerosis and right ventricular diastolic dysfunction in a sample of hypertensive Nigerian patients.

Authors:  Adeseye A Akintunde; Philip B Adebayo; Ademola A Aremu; Oladimeji G Opadijo
Journal:  Croat Med J       Date:  2013-12       Impact factor: 1.351

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.